GreenLight Biosciences Holdings (GRNA) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Medford, MA, アメリカ. 現CEOは Andrey Juan Zarur.
GRNA を有する IPO日 2022-02-03, 280 名の正社員, に上場 NASDAQ Global Market, 時価総額 $45.43M.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
